sware
(2)
Bryan Ennis and the cost of leaving a feature switched off
From regulatory systems at Genzyme to customer success at Veeva, Bryan Ennis has followed the work that piles up behind a software release. At Sware, the co-founder and former CEO is turning that experience towards validation, quality and the adoption of AI.
Ellen Reilly
Ellen Reilly is the Chief Executive Officer and a board member of Sware, a Boston-based software company building Res_Q, an AI-powered GxP validation platform for the life sciences industry. With roughly four decades in life sciences quality and IT, Reilly has worked at Roche, advised clients at PwC, and led the launch of DocuSign's Part 11 product before taking the helm at Sware in 2023. She frames her work as tackling 'validation debt' - the accumulated, unpaid cost of testing and compliance that slows how quickly pharmaceutical and biotech companies can adopt new software.